Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Besifloxacin - Bausch and Lomb

Next Previous
Search
Drug Profile

Besifloxacin - Bausch and Lomb

Alternative Names: Besifloxacin ophthalmic suspension 0.6%; Besivance; BOL-303224-A; ISV-403; Optura; SS 734

Latest Information Update: 29 Dec 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator InSite Vision; SSP Co
  • Developer Bausch & Lomb; Rutgers
  • Class Antibacterials; Antivirals; Azepines; Carboxylic acids; Cyclopropanes; Fluoroquinolones; Small molecules
  • Mechanism of Action DNA gyrase inhibitors; DNA topoisomerase IV inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Bacterial conjunctivitis
  • No development reported COVID 2019 infections; Eye disorders

Most Recent Events

  • 29 Dec 2022 No development reported - Preclinical for COVID-2019 infections in USA (unspecified route)
  • 16 Nov 2020 Preclinical trials in COVID-2019 infections in USA (unspecified route)
  • 16 Jul 2016 No recent reports of development identified for phase-I development in Eye-disorders(In infants) in USA (Ophthalmic, Suspension)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top